RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis
Yuanyang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuying Liu(Tianjin University of Science and Technology), Qianyi Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wen Zhao(Xinjiang Medical University), Junbo Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaomei Lu(Xinjiang Medical University), Feng Lin(Guangzhou University of Chinese Medicine), Xiaowei Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Bicheng Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Taiping Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunyang Xiong(Wenzhou University), Dahan Wen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingyun Yang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 5
Related Papers
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
|Nature Communications|2018|520
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
|Cancer Letters|2021|456
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
|Science Translational Medicine|2020|447